News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
701,086 Results
Type
Article (41959)
Company Profile (330)
Press Release (658797)
Section
Business (207731)
Career Advice (2040)
Deals (35729)
Drug Delivery (91)
Drug Development (81733)
Employer Resources (169)
FDA (16191)
Job Trends (15020)
News (349818)
Policy (32719)
Tag
Academia (2636)
Alliances (50762)
Alzheimer's disease (1274)
Approvals (16142)
Artificial intelligence (152)
Bankruptcy (356)
Best Places to Work (11692)
Biotechnology (239)
Breast cancer (189)
Cancer (1375)
Cardiovascular disease (110)
Career advice (1703)
Cell therapy (284)
Clinical research (65271)
Collaboration (497)
Compensation (261)
COVID-19 (2570)
C-suite (115)
Data (1394)
Diabetes (172)
Diagnostics (6237)
Earnings (85603)
Employer resources (147)
Events (112164)
Executive appointments (399)
FDA (16862)
Funding (433)
Gene therapy (195)
GLP-1 (610)
Government (4380)
Healthcare (18913)
Infectious disease (2662)
Inflammatory bowel disease (112)
Interviews (315)
IPO (16494)
Job creations (3734)
Job search strategy (1456)
Layoffs (428)
Legal (7925)
Lung cancer (198)
Lymphoma (98)
Manufacturing (211)
Medical device (13283)
Medtech (13288)
Mergers & acquisitions (19390)
Metabolic disorders (457)
Neuroscience (1597)
NextGen Class of 2024 (6638)
Non-profit (4579)
Northern California (1707)
Obesity (261)
Opinion (192)
Patents (117)
People (57562)
Phase I (20381)
Phase II (28761)
Phase III (21353)
Pipeline (514)
Postmarket research (2571)
Preclinical (8746)
Radiopharmaceuticals (241)
Rare diseases (261)
Real estate (6083)
Regulatory (21830)
Research institute (2412)
Resumes & cover letters (351)
Southern California (1473)
Startups (3693)
United States (15313)
Vaccines (569)
Weight loss (184)
Date
Last 7 days (585)
Last 30 days (2348)
Last 365 days (35610)
2024 (35447)
2023 (40598)
2022 (51738)
2021 (56306)
2020 (54710)
2019 (47260)
2018 (35589)
2017 (32792)
2016 (32218)
2015 (38280)
2014 (31988)
2013 (27141)
2012 (29286)
2011 (29941)
2010 (28046)
Location
Africa (737)
Arizona (197)
Asia (38494)
Australia (6370)
California (3855)
Canada (1451)
China (309)
Colorado (174)
Connecticut (183)
Europe (83009)
Florida (533)
Georgia (137)
Illinois (387)
Indiana (227)
Maryland (634)
Massachusetts (2989)
Michigan (172)
Minnesota (297)
New Jersey (1111)
New York (1086)
North Carolina (751)
Northern California (1707)
Ohio (146)
Pennsylvania (926)
South America (1121)
Southern California (1473)
Texas (554)
Utah (112)
Washington State (404)
701,086 Results for "biomed valley discoveries inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Fluid Biomed Inc. Raises $27 Million USD in Oversubscribed Series A Financing to Advance World’s First Bioabsorbable Polymer-Based Stent To Treat Brain Aneurysms
December 16, 2024
·
2 min read
Business
Orchestra BioMed Reports First Quarter 2024 Financial Results and Provides a Business Update
Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO, “Orchestra BioMed” or the “Company”), a biomedical company accelerating high-impact technologies to patients through risk-reward sharing partnerships, today reported its first quarter 2024 financial results and provided a business update.
May 13, 2024
·
13 min read
Press Releases
Rejuvenate Biomed and SAS tap AI to develop disease-agnostic drug repurposing discovery tools
August 1, 2024
·
3 min read
Press Releases
Psyence Biomed Highlights Recent Progress on Active Phase IIb Clinical Trial
December 17, 2024
·
6 min read
Pharm Country
Orchestra BioMed to Participate in Jefferies 2024 Global Healthcare Conference
Orchestra BioMed Holdings, Inc. announced that company management will present and be available for one-on-one meetings at the Jefferies Global Healthcare Conference being held in New York, NY, June 4-6, 2024.
May 22, 2024
·
1 min read
Drug Development
BioMed X Start Collaboration in Autoimmunity Research with Servier
The new research team at the BioMed X Institute in Heidelberg will develop a novel strategy to selectively target autoreactive plasma cells in autoimmune disease.
June 26, 2024
·
3 min read
Press Releases
Orchestra BioMed to Participate in Jefferies London Healthcare Conference
November 7, 2024
·
4 min read
Press Releases
Orchestra BioMed to Participate in the Piper Sandler 36th Annual Healthcare Conference
November 27, 2024
·
2 min read
Policy
Orchestra BioMed Announces AVIM Therapy Global Intellectual Property Estate Reaches 110 Issued Patents
Orchestra BioMed Holdings, Inc., a biomedical company accelerating high-impact technologies to patients through risk-reward sharing partnerships, announced the patent estate related to AVIM Therapy has reached 110 patents worldwide.
April 30, 2024
·
8 min read
Business
Orchestra BioMed Reports Full Year 2023 Financial Results and Provides Fourth Quarter Business Update
Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO, “Orchestra BioMed” or the “Company”), a biomedical company accelerating high-impact technologies to patients through risk-reward sharing partnerships, today reported its full year 2023 financial results and provided a fourth quarter business update.
March 27, 2024
·
13 min read
1 of 70,109
Next
